Natural language signatures of psilocybin microdosing
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023752%3A_____%2F22%3A43920881" target="_blank" >RIV/00023752:_____/22:43920881 - isvavai.cz</a>
Alternative codes found
RIV/60461373:22330/22:43925422 RIV/60461373:22810/22:43925422
Result on the web
<a href="https://link.springer.com/article/10.1007/s00213-022-06170-0" target="_blank" >https://link.springer.com/article/10.1007/s00213-022-06170-0</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s00213-022-06170-0" target="_blank" >10.1007/s00213-022-06170-0</a>
Alternative languages
Result language
angličtina
Original language name
Natural language signatures of psilocybin microdosing
Original language description
Rationale Serotonergic psychedelics are being studied as novel treatments for mental health disorders and as facilitators of improved well-being, mental function, and creativity. Recent studies have found mixed results concerning the effects of low doses of psychedelics ("microdosing") on these domains. However, microdosing is generally investigated using instruments designed to assess larger doses of psychedelics, which might lack sensitivity and specificity for this purpose. Objectives Determine whether unconstrained speech contains signatures capable of identifying the acute effects of psilocybin microdoses. Methods Natural speech under psilocybin microdoses (0.5 g of psilocybin mushrooms) was acquired from thirty-four healthy adult volunteers (11 females: 32.09 +/- 3.53 years; 23 males: 30.87 +/- 4.64 years) following a double-blind and placebo-controlled experimental design with two measurement weeks per participant. On Wednesdays and Fridays of each week, participants consumed either the active dose (psilocybin) or the placebo (edible mushrooms). Features of interest were defined based on variables known to be affected by higher doses: verbosity, semantic variability, and sentiment scores. Machine learning models were used to discriminate between conditions. Classifiers were trained and tested using stratified cross-validation to compute the AUC and p-values. Results Except for semantic variability, these metrics presented significant differences between a typical active microdose and the inactive placebo condition. Machine learning classifiers were capable of distinguishing between conditions with high accuracy (AUC approximate to 0.8). Conclusions These results constitute first evidence that low doses of serotonergic psychedelics can be identified from unconstrained natural speech, with potential for widely applicable, affordable, and ecologically valid monitoring of microdosing schedules.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30104 - Pharmacology and pharmacy
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Psychopharmacology
ISSN
0033-3158
e-ISSN
—
Volume of the periodical
239
Issue of the periodical within the volume
9
Country of publishing house
US - UNITED STATES
Number of pages
12
Pages from-to
2841-2852
UT code for WoS article
000807942300001
EID of the result in the Scopus database
2-s2.0-85131581931